Inventor · disambiguated record
Richard Jon Davis
Also filed as: DAVIS RICHARD J · DAVIS RICHARD JON
11 granted patents·5 pending applications·68 citations·filing 2001–2010
90Inventor score
Top patents by PatentIndex Score
16 records- 0191US7326732B2EP2 receptor agonistsPHARMAGENE LAB LTD·Filed 2005·Granted Feb 5, 2008·18 cites·8 claims
- 0289US7803841B2EP2 receptor agonistsASTERAND UK LTD·Filed 2008·Granted Sep 28, 2010·11 cites·13 claims
- 0386US7662839B2EP2 receptor agonistsASTERAND UK LTD·Filed 2007·Granted Feb 16, 2010·7 cites·15 claims
- 0484US7528157B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2006·Granted May 5, 2009·3 cites·24 claims
- 0584US7507754B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2007·Granted Mar 24, 2009·3 cites·41 claims
- 0681US7196089B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2004·Granted Mar 27, 2007·8 cites·30 claims
- 0777US7417068B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2004·Granted Aug 26, 2008·8 cites·15 claims
- 0875US7569602B2Furan derivatives as EP4 receptor antagonistsASTERAND UK LTD·Filed 2004·Granted Aug 4, 2009·6 cites·13 claims
- 0973US8080567B2EP2 receptor agonistsOXFORD ALEXANDER WILLIAM·Filed 2006·Granted Dec 20, 2011·2 cites·21 claims
- 1068US7858644B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2009·Granted Dec 28, 2010·0 cites·23 claims
- 1165US6780839B2Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)PHARMAGENE LAB LTD·Filed 2001·Granted Aug 24, 2004·2 cites·3 claims
- 1261US2008306117A1Ep4 receptor antagonistsASTERAND UK LTD·Filed 2008·Application pending·0 cites
- 1355US2006147384A1Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)PHARMAGENE LAB LTD·Filed 2006·Application pending·0 cites
- 1454US2004191238A1Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)PHARMAGENE LAB LTD·Filed 2004·Application pending·0 cites
- 1551US2011039759A1Use of Secretin-Receptor Ligands in Treatment of Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD)NOVARTIS AG·Filed 2010·Application pending·0 cites
- 1647US2004241154A1Secretin for the treatment of asthmaFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →